* Trial enrolled over 30,000 adult & elderly participants across 4 continents; 100% of SARS-CoV-2...
CHENGDU, China, Sept. 9, 2021 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.
(Clover)
2021-09-09 19:51
2172
* SPECTRA enrolled over 29,000 adult and elderly participants across four continents achieving hi...
* Pending WHO EUL for its COVID-19 vaccine candidate, Clover is committed to providing 64 million...
* Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover...
* The publication is available as a pre-print on bioRxiv * Preclinical data demonstrates that a ...
* Over 22,000 participants aged 18 years or older are expected to be enrolled in SPECTRA acrossLa...
* Series C financing brings total capital raised in the last 12 months to over US$ 400 million (>R...
* Adjuvanted S-Trimer COVID-19 vaccine candidates demonstrated favorable safety and tolerability ...
* Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-...